210 related articles for article (PubMed ID: 24987755)
1. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
4. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging.
Yang X; Xing Z; She D; Lin Y; Zhang H; Su Y; Cao D
BMC Med Imaging; 2022 May; 22(1):105. PubMed ID: 35644621
[TBL] [Abstract][Full Text] [Related]
5. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility-weighted imaging: the value in cerebral astrocytomas grading.
Zhang H; Tan Y; Wang XC; Qing JB; Wang L; Wu XF; Zhang L; Liu QW
Neurol India; 2013; 61(4):389-95. PubMed ID: 24005730
[TBL] [Abstract][Full Text] [Related]
8. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Xing Z; You RX; Li J; Liu Y; Cao DR
Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
[TBL] [Abstract][Full Text] [Related]
10. Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT.
Qin JB; Zhang H; Wang XC; Tan Y; Wu XF
Oncol Lett; 2019 Sep; 18(3):2763-2770. PubMed ID: 31452754
[TBL] [Abstract][Full Text] [Related]
11. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
[TBL] [Abstract][Full Text] [Related]
12. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
13. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.
Haris M; Husain N; Singh A; Husain M; Srivastava S; Srivastava C; Behari S; Rathore RK; Saksena S; Gupta RK
J Comput Assist Tomogr; 2008; 32(6):955-65. PubMed ID: 19204461
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility-weighted imaging in grading brain astrocytomas.
Li C; Ai B; Li Y; Qi H; Wu L
Eur J Radiol; 2010 Jul; 75(1):e81-5. PubMed ID: 19726149
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
17. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
[TBL] [Abstract][Full Text] [Related]
18. [Application of susceptibility weighted imaging in revealing intratumoral blood products and grading gliomas].
Zhang W; Zhao J; Guo D; Zhong W; Shu J; Luo Y
J Radiol; 2010 Apr; 91(4):485-90. PubMed ID: 20514004
[TBL] [Abstract][Full Text] [Related]
19. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J
Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
